Episodes

  • Bitcoin flirts with $100K as Trump’s win fuels rally and Gensler quits - Crypto Roundup

    Bitcoin flirts with $100K as Trump’s win fuels rally and Gensler quits - Crypto Roundup
    Nov 22 2024
    Proactive's Billy Farrington joined Stephen Gunnion with more about the factors propelling bitcoin’s price near the $100,000 milestone. Farrington highlighted a remarkable 130% year-to-date gain, with much of the increase occurring in November 2024. Key developments include Donald Trump’s presidential election win, which sparked optimism due to his pro-crypto stance and promises to reshape US crypto regulation. The resignation of SEC chair Gary Gensler, seen as a crypto critic, has also been a tailwind. Farrington noted, “Trump made a raft of pro-crypto promises... and it kind of looks like he's already made good on that promise [about Gensler].” Other catalysts discussed were the approval of bitcoin ETFs, bringing billions of dollars into the market, and the bitcoin halving event in April 2024. Together, these factors create a fertile environment for bitcoin’s continued growth. Stay tuned to Proactive's YouTube channel for more updates and insights on the cryptocurrency market. Don't forget to like this video, subscribe to our channel, and hit the notification bell to stay informed. #Bitcoin #CryptoNews #BitcoinRally #BitcoinETF #Cryptocurrency #Trump2024 #CryptoMarket #CryptoInvesting #BitcoinHalving#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    7 mins
  • Happy Creek Minerals unveils promising results from 2024 fieldwork on Silverboss and Hen-DL projects

    Happy Creek Minerals unveils promising results from 2024 fieldwork on Silverboss and Hen-DL projects
    Nov 22 2024
    Happy Creek Minerals CEO Jason Bahnsen joined Steve Darling from Proactive to share exciting findings from the company’s 2024 reconnaissance fieldwork on its Silverboss and Hen-DL properties in south-central British Columbia. During the field season, the company collected 56 rock, 113 soil, and 17 stream sediment samples, which revealed anomalous copper, gold, and silver values, underscoring the potential for discovering significant mineral deposits on both projects. On the Hen-DL property, a standout discovery was a large boulder near the Eureka thrust fault, yielding highly anomalous results for nickel, chromium, cobalt, and platinum. This boulder is believed to originate from a relatively unexplored area of the property, signaling the potential of the mineralized system. Similarly, on the DL property, the team identified a large gabbro-pyroxenite rock boulder, which also exhibited highly anomalous assay results for nickel, chromium, cobalt, and platinum, further pointing to mineralization associated with the Eureka fault area. “These results validate the geological potential of our properties,” said Bahnsen. “We are excited about the discoveries made during the 2024 field season and the opportunities they present for advancing exploration on both the Silverboss and Hen-DL projects.” The company plans to further investigate the source of these boulders and the mineralized zones, emphasizing the significant exploration potential within these promising British Columbia assets. #proactiveinvestors #happycreekmineralsltd #tsxv #hpy #SilverBossProject #HenArtDL #GoldExploration #CopperDiscovery #MiningNews #ProactiveInterviews #GeologyResearch #DrillTargets #TungstenPotential #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    5 mins
  • Rome Resources says drilling reveals significant tin mineralisation at Kalayi prospect in DRC

    Rome Resources says drilling reveals significant tin mineralisation at Kalayi prospect in DRC
    Nov 22 2024
    Rome Resources Plc (AIM:RMR) CEO Paul Barrett talked with Proactive's Stephen Gunnion about the company's latest drilling updates at the Kalayi and Mont Agoma prospects, part of its Bisie North project in the DRC. Barrett highlighted encouraging assay results from the first two of twelve diamond drill holes at Kalayi, showing high-grade tin zones. "We're seeing quite well-defined tin zones in each of the holes we've drilled," he noted, emphasising the simplicity of potential mining operations due to the surface-level deposits. At Mont Agoma, Barrett discussed visible intersections of tin, copper, and zinc, calling the polymetallic discovery a potential "game-changer." The company expects assay results for two drill holes in the coming weeks, with Barrett pointing to a 200-meter-wide sulfide zone and the expectation of improving grades as drilling progresses southward. The ongoing drill program is set to conclude early January 2024, slightly delayed due to weather conditions. Barrett also touched on discussions with potential strategic investors who approached the company, encouraged by its proximity to Alphamin Resources' tin project. Visit Proactive's YouTube channel for more updates. Don’t forget to like the video, subscribe to the channel, and enable notifications for future content. #RomeResources #TinMining #CopperExploration #ZincDeposits #BisieNorth #DRCMining #StrategicInvestments #MineralExploration #MiningUpdates #ProactiveInvestors#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    5 mins
  • IQ-AI adds key board member as its Imaging Biometrics subsidiary expands GE partnership

    IQ-AI adds key board member as its Imaging Biometrics subsidiary expands GE partnership
    Nov 22 2024
    Michael Schmainda, CEO of IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) subsidiary Imaging Biometrics, and IQ-AI recently-appointed non-executive director, Dr Al Musella, discuss the latest developments at the company with Proactive's Stephen Gunnion. Schmainda discussed a renewed agreement with GE Healthcare, which streamlines the distribution of Imaging Biometrics’ IB Neuro and IB Delta T1 platforms. These tools aim to improve the assessment and treatment of brain tumours, offering radiologists more precise and actionable insights. Schmainda emphasised that this partnership, involving a novel pricing model based on MRI scanners, could accelerate the adoption of the technology across GE’s extensive customer base. He also highlighted the potential impact on the market for treating high-grade gliomas and brain metastases. Dr Musella shared his journey, from medical practitioner to advocate for brain tumour patients and the pivotal role Imaging Biometrics technology plays in improving treatment decisions. He discussed the expanded access program for gallium maltolate and the company’s focus on integrating its technology into clinical trials and everyday practice. "Imaging Biometrics had the best technology that’s widely available, relatively inexpensive, and simple to use," Musella said. He expressed excitement about helping IQ-AI make their tools the standard of care for brain MRI scans. Visit Proactive's YouTube channel for more interviews like this. Don’t forget to like, subscribe, and enable notifications for updates! #IQAI #ImagingBiometrics #BrainTumorCare #MedicalTechnology #GEHealthcare #ClinicalTrials #GalliumMaltolate #BrainMRI #CancerTreatment #NeuroscienceTech #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    8 mins
  • CleanTech Lithium's Gordon Stein on achieving pilot-sale lithium production milestone

    CleanTech Lithium's Gordon Stein on achieving pilot-sale lithium production milestone
    Nov 22 2024
    CleanTech Lithium PLC (AIM:CTL, OTCQX:CTLHF) chief financial officer Gordon Stein talked with Proactive's Stephen Gunnion about the company's major milestone of producing battery-grade lithium. This marks what could be the first instance of producing lithium from Chile at a pilot scale using Direct Lithium Extraction (DLE) technology. Stein highlighted that the process has been three years in the making, starting with the identification of substantial lithium resources at Laguna Verde in Chile. "It’s a fantastic achievement," Stein commented. This milestone underscores the company's commitment to sustainable lithium production. Looking forward, Stein shared that CleanTech Lithium is advancing a pre-feasibility study and engaging with potential strategic partners, including a household-name car company, to explore future collaboration opportunities. Additionally, he noted progress on regulatory and operational plans in Chile. Stay updated on CleanTech Lithium's innovative journey—subscribe to Proactive’s YouTube channel for more exclusive interviews and insights. Don’t forget to like, subscribe, and enable notifications to stay informed about future updates. #CleanTechLithium #lithium #BatteryGradeLithium #DLEResearch #ChileLithiumProduction #CleanEnergy #SustainableMining #LagunaVerde #LithiumInnovation #ProactiveInterview #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    6 mins
  • Nostra Terra CEO discusses £500,000 fund raise and expansion plans

    Nostra Terra CEO discusses £500,000 fund raise and expansion plans
    Nov 22 2024
    Nostra Terra Oil and Gas Company PLC (AIM:NTOG, OTC:NTOGF) CEO Paul Welch talked with Proactive about the company’s recent milestones and future plans. Welch detailed the completion of a £500,000 fundraise, which brought new institutional investors on board, with a spike in its shares price resulting in the shares being issued at larger than planned discount. He explained that the funds are allocated for the second phase of a workover program, targeting production increases from five additional wells. The first phase of the program delivered a 30-barrel-per-day production boost, with the potential for an additional 15 to 30 barrels per day once a water flood project in the northern field is fully operational. Welch anticipates similar success in the second phase, with projections of 50 additional barrels per day. He emphasised the transformative impact of these initiatives, estimating a fivefold increase in monthly cash flow once the projects are completed. Visit Proactive’s YouTube channel for more updates, and don't forget to like, subscribe, and enable notifications for future content. #NostraTerra #OilProduction #PaulWelch #EnergyInvesting #OilAndGas #FundRaise #CashFlow #EnergySector #ProactiveInvestors #OilExploration #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    5 mins
  • NextEnergy Solar Fund: 11% dividend yield, share buybacks & future growth plans

    NextEnergy Solar Fund: 11% dividend yield, share buybacks & future growth plans
    Nov 22 2024
    NextEnergy Solar Fund Ltd investment director and UK legal counsel Stephen Rosser talked with Proactive about the fund's latest developments, including highlights from its interim results. Rosser shared that the fund generated £45 million in cash from producing nearly 600-gigawatt hours of clean electricity. He emphasised the fund’s 11% dividend yield and its strong cash coverage, which enhances its appeal as an attractive investment. Rosser discussed the fund's efforts to narrow the discount to net asset value through strategies such as a £20 million share buyback program and a capital recycling initiative. He revealed the completion of phase three, which included selling the 50 MW Staughton asset for £30.3 million—a 21.5% premium to its carrying value. He also outlined a positive outlook for the renewable energy sector, citing government commitments to clean power and a promising pipeline of projects within the fund. "Plenty of reasons to be positive and potential to drive value for shareholders," Rosser remarked. The company remains focused on disciplined capital allocation and delivering cash-covered dividends. Visit Proactive's YouTube channel for more interviews like this. Don't forget to like the video, subscribe, and turn on notifications for updates. #NextEnergySolarFund #RenewableEnergy #SolarPower #InvestmentOpportunity #GreenEnergy #DividendStocks #SustainableInvesting #ShareBuyback #EnergyStorage #ProactiveInterviews #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    9 mins
  • Just the Facts: Tryptamine Therapeutics doses first patient in obesity-focused psilocin study

    Just the Facts: Tryptamine Therapeutics doses first patient in obesity-focused psilocin study
    Nov 22 2024
    Proactive’s Tylah Tully breaks down Just the Facts of the latest news from Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF). The company has dosed the first participant in its Phase 1b trial of TRP-8803, a psilocin-based IV infusion, targeting obese individuals. The trial, conducted at CMAX Clinical Research in Adelaide, involves three obese participants and aims to compare pharmacokinetics between obese and non-obese groups. The initial treatment lasted 140 minutes. TRP-8803, designed for faster onset and precise control of the psychedelic state, offers neuroplastic benefits that may lead to adaptive changes in the brain, enhancing clinical outcomes. The trial builds on earlier Phase 1 results that demonstrated safety, efficacy, and optimal dosing rates. Interim results from the obese cohort are expected before year-end. This data will refine dosing protocols for future Phase 2 trials, which will explore specific indications, including weight-related conditions such as Binge Eating Disorder. The study highlights the cost-effectiveness of the initiative and its role in expanding the company’s dataset for broader applications. Tryptamine’s management is currently evaluating opportunities for Phase 2 trials and plans to provide updates as they progress. #ProactiveInvestors #TryptamineTherapeutics #ASX #TRP8803 #PsilocinResearch #Phase1bTrial #ObesityResearch #Neuroplasticity #PsilocybinAlternative #ClinicalTrials #InnovativeMedicine #CMAXResearch #TherapeuticAdvancements #PsychedelicTherapies #HealthOutcomes #Pharmacokinetics #MentalHealthResearch #BingeEatingDisorder #FutureOfMedicine #PatientCare #DataDrivenResearch #Phase2Planning
    Show more Show less
    2 mins